In addition, DC vaccines loaded with specific antigens such as AFP, MAGE-1, and GPC-3 enhanced IFN-γ-generating CTL responses against tumor antigens in trials combining TACE or surgical resection [96]. The gene discussed is IFNG; the disease is neoplasm.